Produkty 4075-14-3

CAS 4075-14-3 występuje w naszej ofercie pod nazwami: 2Alpha-Hydroxy Testosterone, >95% (HPLC), 2alpha-Hydroxy Testosterone (1mg/ml in Acetonitrile), 2α-Hydroxytestosterone, Testosterone impurity 7. Oferty producentów: TRC, Biosynth, MedChemExpress. Dostępne opakowania: 50mg, 5mg, 1x1ml, 10mg, 25mg, Get quote.

2Alpha-Hydroxy Testosterone, >95% (HPLC)
TRC
  • opakowanie: 50mg, 5mg
  • Warianty: 2
Zobacz produkt
2alpha-Hydroxy Testosterone (1mg/ml in Acetonitrile)
TRC
  • opakowanie: 1x1ml
  • Warianty: 1
Zobacz produkt
2α-Hydroxytestosterone
Biosynth
  • opakowanie: 10mg, 5mg, 25mg
  • Warianty: 3
Zobacz produkt
Testosterone impurity 7
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R,8R,9S,10R,13S,14S,17S)-2,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 4075-14-3) to związek chemiczny o wzorze sumarycznym C19H28O3 i masie molowej 304.4 g/mol. Nazwa systematyczna IUPAC: (2R,8R,9S,10R,13S,14S,17S)-2,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: ZOIPFFUVGMVQGE-DTQPDNRZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O3
Masa molowa304.4 g/mol
Nazwa IUPAC(2R,8R,9S,10R,13S,14S,17S)-2,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyZOIPFFUVGMVQGE-DTQPDNRZSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)[C@@H](C[C@]34C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (2alpha,17beta)-2,17-Dihydroxyandrost-4-en-3-one, 2alpha-Hydroxytestosterone, 2alpha,17beta-dihydroxyandrost-4-en-3-one, 2a-Hydroxy Testosterone, 2alpha-Hydroxy Testosterone (1mg/ml in Acetonitrile), 2alpha-hydroxy testosterone
Powiązane formy tego związku
(2S,8R,9S,10R,13S,14S,17S)-2,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
Izomery (ten sam wzór sumaryczny)
methyl 12-oxo-12-phenyldodecanoate C19H28O3
(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C19H28O3
(3R,5R,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione C19H28O3
(6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(1R,3bR,5aS,9aS,9bS)-1-(hydroxymethyl)-1,9a-dimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(6R,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(2R,3bR,5aS,9aS,9bS)-2-hydroxy-1,1,9a-trimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(3S,4R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O3
(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-one C19H28O3
(1S,3aS,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,5,5a,6,9,9b,10,11-decahydroindeno[4,5-h]isochromen-7-one C19H28O3